NuCicer, a crop genetics company pioneering ultra-high protein varieties of chickpea, announced the closing of a $4.5 million Series Seed financing round.

Lever VC, an early-stage venture capital firm focused on innovative technologies and brands in the alternative protein space, led NuCicer's round. Other participants included The House Fund, a fund backed by the University of California Endowment, as well as Trellis Road and Lifely VC.